Phosphatidylinositol 3-kinase and NF-κB involved in epidermal growth factor-induced Matrix metalloproteinase-9 expression

Journal of Cancer Molecules

Volumn 4, Issue 2, 2008, Pages 55-60

  Moulik, Shuvojit ^a   Sen, Triparna ^a   Dutta, Anindita ^a   Banerji, Aniruddha ^a   Ghosh, Chinmoy ^a   Das, Shamik ^a   Chatterjee, Amitava ^a  

^a CHITTARANJAN NATIONAL CANCER INSTITUTE   (India)

Author keywords

Curcumin; EGFR; MMP 9; NF B; P13 K

Indexed keywords

CURCUMIN; EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; GELATINASE B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR;

ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CELL NUCLEUS; CONTROLLED STUDY; ENZYME INDUCTION; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; METASTASIS POTENTIAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RECEPTOR DOWN REGULATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING; ZYMOGRAPHY;

EID: 46149094651     PISSN: 18160735     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Reissmann PT, Koga H, Figlin RA, Holmes EC, Slamon DJ. Amplification and overexpression of the cyclin D1 and epidermal growth factor receptor genes in non-small cell lung cancer. Lung Cancer Study Group. J Cancer Res Clin Oncol 125: 61-70, 1999.
2. Turkeri LN, Sakr WA, Wykes SM, Grignon DJ, Pontes JE, Macoska JA. Comparative analysis of epidermal growth factor receptor gene expression and protein product in benign, premalignant, and malignant prostate tissue. Prostate 25: 199-205, 1994.
3. Goldstein NS, Armin M. Epidermal growth factor receptor immunohistochemical reactivity in patients with American Joint Amplification and overexpression of the cyclin D1 and epidermal growth factor receptor genes in non-small cell lung cancer. Lung Cancer Study Group. Cancer 92: 1331-1346, 2001.
4. Frederick L, Wang XY, Eley G, James CD. Diversity and frequency of epidermal growth factor receptor mutations in human glioblastomas. Cancer Res 60; 1383-1387, 2000.
5. Carpenter G. Receptor for epidermal growth factor and other polypeptide mitogen. Annu Rev Biochem, 56: 881-914, 1987.
6. Jorrisen RN, Walker F, Pouliot N, Garret TP, Ward CW, Burgess AW. Epidermal growth factor: mechanism of activation and signaling. Exp Cell Res 284: 31-53, 2003.
7. Birkedal-Hansen H, Moore WG, Bodden MK, Windsor LJ, Birkedal-Hansen B, DeCarlo A, Engler JA. Matrix metalloproteinase: a review. Crit Rev Oral Biol Med 4: 197-250, 1993.
8. Cox G, O'Byrne KJ. Matrix metalloproteinases and cancer. Anticancer Res 21: 4207-4220, 2001.
9. Kondapaka SB, Fridman R, Reddy KB. Epidermal growth factor and amphiregulin upregulate matrix metalloproteinase 9 (MMP 9) in human breast cancer cells. Int J Cancer 70: 722-726, 1997.
10. Cox G, Jones JL, O'Byrne KJ. MMP 9 and the epidermal growth factor receptor signal pathway in operable non-small cell lung cancer. Clin Cancer Res 6: 2349-2355, 2000.
11. Roskoski R Jr. The ErbB/HER receptor protein-tyrosine kinases and cancer. Biochem Biophys Res Commun 319: 1-11, 2004.
12. Hunter T, Cooper JA. Epidermal growth factor induces rapid tyrosine phosphorylation of proteins in A431 human tumor cells. Cell 24: 741-752, 1981.
13. Oda K, Matsuoka U, Funahashi A, Kitano H. A comprehensive pathway map of epidermal growth factor receptor signaling. Mol System Biol 1: 8-23, 2005.
14. Lin SY, Makino K, Xia W, Matin A, Wen Y, Kwong KY, Bourguignon L, Hung MC. Nuclear localization of EGF receptor and its potential new role as a transcription factor. Nat Cell Biol 3: 802-808, 2001.
15. Sebastian S, Settleman J, Reshkin SJ, Azzarati A, Bellizzi A, Paradiso A. The complexity of targeting EGFR signaling in cancer: from expression to turnover. Biochim Biophys Acta 1766: 120-139, 2006.
16. Fridman R, Toth M, Chvyrkova I, Meroueh OS, Mobashery S. Cell surface association of matrix metalloproteinase-9 (gelatinase B). Cancer Metastasis Rev 22: 153-166, 2003.
17. Sorilas A, Karameris A, Arnogiannaki N, Ardavanis A, Bassilopoulus P, Trangas T, Talieri M. Overexpression of matrix metalloproteinase 9 in human breast cancer: a favorable indicator in node-negative patients. Br J Cancer 84; 1488-1496, 2001.
18. O'Charoenrat P, Modjtahedi H, Evans P, Court WJ, Box GM, Eccles SA. Epidermal growth factor-like ligands differentially upregulate matrix metalloproteinese 9 in head and neck squamous carcinoma cells. Int J Cancer 60: 1121-1128, 2000.
19. McCawley LJ, O'Brien P, Hudson LG. Epidermal growth factor (EGF) and scatter factor/hepatocyte growth factor (SF/HGF)-mediated keratinocyte migration is coincident with induction of matrix metalloproteinase (MMP)-9. J Cell Physiol 176: 255-265, 1998.
20. Le Page C, Koumakpayi IH, Lessard L, Mes-Masson AM, Saad F. EGFR and Her-2 regulate the constitutive activation of NF-κB in PC-3 prostate cancer cells. Prostate 65: 130-140, 2005.
21. Lin LI, Ke YF, Ko YC, Lin JK. Curcumin inhibits SK-Hep-1 hepatocellular carcinoma cell invasion in vitro and suppresses matrix metalloproteinase-9 secretion. Oncology 55: 349-353, 1998.
22. Lin CL, Lin JK. Curcumin: a potential cancer chemopreventive agent through suppressing NF-κB signaling. J Cancer Mol 4: 11-16, 2008.
23. Kortula L, Kumar R. Inhibitory effects of curcumin on epidermal growth factor receptor kinase activity in A431 cells. Biochim Biophys Acta 1224: 597-600, 1994.
24. Cao H, Lei ZM, Bian L, Rao CV. Functional nuclear epidermal growth factor receptors in human choriocarcinoma JEG-3 cells and normal human placenta. Endocrinology 136: 3163-3172, 1995.
25. Lo HW, Hung MC. Nuclear EGFR signaling network in cancers: linking EGFR pathway to cell cycle progression, nitric oxide pathway and patient survival. Br J Cancer 94: 184-188, 2006.
26. Kamio T, Shigematsu K, Sou H, Kawai K, Tsuchiyama H. Immunohistochemical expression of epidermal growth factor receptors in human adrenocortical carcinoma. Human Pathol 21: 277-282, 1999.
27. Lipponen P, Eskelinen M. Expression of epidermal growth factor receptor in bladder cancer as related to established prognostic factors, oncoprotein (c-erbB-2, p53) expression and long term prognosis. Br J Cancer 69: 1120-1125, 1994.
28. Lo H-W, Hsu S-C, Ali-Seyed M, Gunduz M, Xia W, Wei Y, Bartholomeusz G, Shih J-Y, Hung M-C. Nuclear translocation of EGFR and STAT 3 in the activation of iNOS/NO pathway. Cancer Cell 7; 575-589, 2005.
29. Marti U, Ruchti C, Kampf J, Thomas GA, William ED, Peter HJ, Gerber H, Burgi U. Nuclear localization of epidermal growth factor and epidermal growth factor receptors in human thyroid tissues. Thyroid 11: 137-145, 2001.